| |
|
|
|
Matinas BioPharma Holdings- Inc.  
|
|
0.3625 0.002 (0.01%) |
08-15 10:48 |
|
Open: |
0.37 |
Pre close: |
0.36 |
Target:
|
0.48
|
|
High: |
0.37 |
Low: |
0.37 |
Resistance:
|
0.41
0.45
|
|
Volume: |
19,615 |
Market Cap: |
34M |
Support:
|
0.34
0.29
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.36
 |
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
0.37 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.53 |
Stochastic Oscillator |
%K(14,3):
|
19.32 |
|
MA(250): |
0.94 |
%D(3): |
20.16 |
|
Average Volume(K) |
3-Month: |
40527
|
52-Week |
High:
|
1.60 |
|
10-Days: |
7800 |
Low: |
0.32 |
|
RSI |
RSI(14):
|
42.86 |
Change(%): |
-72.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-200.7 |
Shares Out. (M) |
94.58 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-93.7 |
Shares Float (M) |
81.63 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.80 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
100.0 |
% Held by Institutions |
17.00 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1609 |
|
Book Value (p.s.) |
12.370 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.23 |
P/S |
0.00 |
|
Operating Margin |
-9799.84 |
Levered Free Cash Flow
(M) |
-7.65 |
P/CF |
-3.04 |
|
|
|
|
|
|
